Why Tyson Foods Looks Like a Tasty Treat for Income Investors Right Now
marketbeat.com
Want to monitor ANVS?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor ANVSannovis bio, inc. , a clinical stage drug platform company, develops drugs to treat neurodegeneration. its lead compound is anvs401, which is in phase 2a clinical trials for the treatment of alzheimer's disease (ad), parkinson's disease, alzheimer's disease in down syndrome, and other chronic neurodegenerative disorders.